Prasugrel in Clinical PracticeBHATT, Deepak L.The New England journal of medicine. 2009, Vol 361, Num 10, pp 940-942, issn 0028-4793, 3 p.Article

Identification of and management approaches for the high-risk patientBHATT, Deepak L.The American journal of cardiology. 2006, Vol 98, Num 12, pp 22-29, issn 0002-9149, 8 p., SUPConference Paper

Anti-Inflammatory Agents and Antioxidants as a Possible Third Great Wave in Cardiovascular Secondary PreventionBHATT, Deepak L.The American journal of cardiology. 2008, Vol 101, Num 10, issn 0002-9149, 4D-13D, SUPArticle

Comparative benefits of clopidogrel and aspirin in high-risk patient populations: Lessons from the CAPRIE and CURE studiesHIRSH, Jack; BHATT, Deepak L.Archives of internal medicine (1960). 2004, Vol 164, Num 19, pp 2106-2110, issn 0003-9926, 5 p.Article

Clinical aspects of platelet inhibitors and thrombus formationMEADOWS, Telly A; BHATT, Deepak L.Circulation research. 2007, Vol 100, Num 9, pp 1261-1275, issn 0009-7330, 15 p.Article

Antiplatelet therapies in combination for the treatment of patients with stable and unstable coronary artery diseaseAVILES, Ronnier J; BHATT, Deepak L.Journal of thrombosis and thrombolysis. 2002, Vol 13, Num 3, pp 177-182, issn 0929-5305Article

Appropriate use of drug-eluting stents : balancing the reduction in restenosis with the concern of late thrombosisBAVRY, Anthony A; BHATT, Deepak L.Lancet (British edition). 2008, Vol 371, Num 9630, pp 2134-2143, issn 0140-6736, 10 p.Article

In Vivo Markers of Oxidative Stress and Therapeutic InterventionsTSIMIKAS, Sotirios.The American journal of cardiology. 2008, Vol 101, Num 10, issn 0002-9149, 34D-42D, SUPArticle

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialBHATT, Deepak L; TOPOL, Eric J.The American heart journal. 2004, Vol 148, Num 2, pp 263-268, issn 0002-8703, 6 p.Article

The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: To what extent should the results be generalizable?GERSCHUTZ, Gregory P; BHATT, Deepak L.The American heart journal. 2003, Vol 145, Num 4, pp 595-601, issn 0002-8703, 7 p.Article

Antiplatelet Therapy and Proton Pump Inhibition: Clinician UpdateMOUKARBEL, George V; BHATT, Deepak L.Circulation (New York, N.Y.). 2012, Vol 125, Num 2, pp 375-380, issn 0009-7322, 6 p.Article

Acute myocardial infarction and drug-eluting stents : A green light for their use or time for measured restraint?BAVRY, Anthony A; BHATT, Deepak L.The American heart journal. 2007, Vol 153, Num 5, pp 719-721, issn 0002-8703, 3 p.Article

Effect of statin pretreatment and baseline c-reactive protein on outcomes following percutaneous coronary interventionCHAN, Albert W; BHATT, Deepak L.Cardiovascular reviews & reports. 2003, Vol 24, Num 11, pp 577-582, issn 0197-3118, 6 p.Article

Need to test the arterial inflammation hypothesisBHATT, Deepak L; TOPOL, Eric J.Circulation (New York, N.Y.). 2002, Vol 106, Num 1, pp 136-140, issn 0009-7322Article

Renal Denervation Therapy for HypertensionTHUKKANI, Arun K; BHATT, Deepak L.Circulation (New York, N.Y.). 2013, Vol 128, Num 20, pp 2251-2254, issn 0009-7322, 4 p.Article

Oxidative Stress and Heart DiseaseBHATT, Deepak L; PASHKOW, Fredric J.The American journal of cardiology. 2008, Vol 101, Num 10, issn 0002-9149, 88 p., SUPSerial Issue

Atherosclerosis : Disease biology affecting the coronary vasculatureLIBBY, Peter.The American journal of cardiology. 2006, Vol 98, Num 12, pp 3-9, issn 0002-9149, 7 p., SUPConference Paper

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromesBHATT, Deepak L; TOPOL, Eric J; MD et al.JAMA, the journal of the American Medical Association. 2000, Vol 284, Num 12, pp 1549-1558, issn 0098-7484Article

Thrombin, an ideal target for pharmacological inhibition: A review of direct thrombin inhibitorsGURM, Hitinder S; BHATT, Deepak L.The American heart journal. 2005, Vol 149, Num 1, pp S43-S53, issn 0002-8703, SUPArticle

The importance of intravenous antiplatelet therapy with abciximab during percutaneous coronary intervention in diabetic patientsBHATT, Deepak L; CHEW, Derek P; TOPOL, Eric I et al.Cardiovascular reviews & reports. 2001, Vol 22, Num 3, pp 161-164, issn 0197-3118Article

Regionalization of Care for ST-Segment Elevation Myocardial Infarction : Is It Too Soon?POTTENGER, Brent C; DIERCKS, Deborah B; BHATT, Deepak L et al.Annals of emergency medicine. 2008, Vol 52, Num 6, pp 677-685, issn 0196-0644, 9 p.Article

Why Have Antioxidants Failed in Clinical Trials?STEINHUBL, Steven R.The American journal of cardiology. 2008, Vol 101, Num 10, issn 0002-9149, 14D-19D, SUPArticle

Natural Products as a Robust Source of New Drugs and Drug Leads : Past Successes and Present Day IssuesRISHTON, Gilbert M.The American journal of cardiology. 2008, Vol 101, Num 10, issn 0002-9149, 43D-49D, SUPArticle

A review of high-dose statin therapy : targeting cholesterol and inflammation in atherosclerosisPATEL, Taral N; SHISHEHBOR, Mehdi H; BHATT, Deepak L et al.European heart journal. 2007, Vol 28, Num 6, pp 664-672, issn 0195-668X, 9 p.Article

Clinical evaluation of clopidogrel across the whole spectrum of indications : primary and secondary prevention of coronary artery diseaseDE OLIVEIRA, Eduardo I; BHATT, Deepak L.European heart journal supplements. 2006, Vol 8G, issn 1520-765X, G10-G14Article